INFORMATION STATEMENT

Company

GT Biopharma, Inc.

Filed

March 22, 2002

Accession Number

0001099910-02-000090

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →